- Market Realist•5 days ago
23.1% of analysts gave United Therapeutics (UTHR) a “buy” recommendation while 69.2% of analysts rated the company a “hold.”
- Zacks•6 days ago
The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
After hours: 87.000.04 (0.05%) as of 5:21 PM EDT
|Bid||60.09 x 100|
|52wk Range||55.00 - 133.62|
|Day's Range||85.60 - 87.53|
|Avg Vol (3m)||1,093,414|
As of 4:00 PM EDT. Market closed.